Drug intelligence / Profile preview

carboxymethylcellulose + stabilized oxychlorocomplex

Development stage
Phase 4
Lead developer
Allergan
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Ophthalmic
01

Overview

carboxymethylcellulose + stabilized oxychlorocomplex is a topical ophthalmic lubricant formulation used for the symptomatic relief of dry eye syndrome. The active ingredient, carboxymethylcellulose (CMC), is a high-molecular-weight cellulose derivative that acts as a demulcent and mucomimetic, providing physical lubrication and increasing the residence time of the tear film on the ocular surface. The formulation is preserved with stabilized oxychlorocomplex (SOC), commercially known as PURITE, which is an oxidative preservative system composed of chlorite, chlorate, and trace amounts of chlorine dioxide. Unlike traditional preservatives such as benzalkonium chloride, SOC provides antimicrobial activity within the container but rapidly dissociates into natural tear components (water, oxygen, sodium, and chloride ions) upon exposure to light and the ocular surface, thereby minimizing preservative-induced ocular surface toxicity. This specific combination was evaluated in a randomized controlled trial by Chulalongkorn University to compare its efficacy and safety against carboxymethylcellulose alone in patients with moderate to severe dry eye.

Brand names
Refresh TearsRefresh Liquigel
Other names
0.5% carboxymethylcellulose with 0.005% stabilized oxychlorocomplexCMC-SOCCMC with PURITE
02

Targets

Lipid A

Beyond the preview

Go deeper on carboxymethylcellulose + stabilized oxychlorocomplex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carboxymethylcellulose + stabilized oxychlorocomplex.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call